These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
9. OX40 ligand-transduced tumor cell vaccine synergizes with GM-CSF and requires CD40-Apc signaling to boost the host T cell antitumor response. Gri G; Gallo E; Di Carlo E; Musiani P; Colombo MP J Immunol; 2003 Jan; 170(1):99-106. PubMed ID: 12496388 [TBL] [Abstract][Full Text] [Related]
10. OX40 ligand expressed in glioblastoma modulates adaptive immunity depending on the microenvironment: a clue for successful immunotherapy. Shibahara I; Saito R; Zhang R; Chonan M; Shoji T; Kanamori M; Sonoda Y; Kumabe T; Kanehira M; Kikuchi T; So T; Watanabe T; Takahashi H; Iwabuchi E; Tanaka Y; Shibahara Y; Sasano H; Ishii N; Tominaga T Mol Cancer; 2015 Feb; 14():41. PubMed ID: 25744203 [TBL] [Abstract][Full Text] [Related]
11. Constitutive OX40/OX40 ligand interaction induces autoimmune-like diseases. Murata K; Nose M; Ndhlovu LC; Sato T; Sugamura K; Ishii N J Immunol; 2002 Oct; 169(8):4628-36. PubMed ID: 12370402 [TBL] [Abstract][Full Text] [Related]
12. OX40 ligand expressed by DCs costimulates NKT and CD4+ Th cell antitumor immunity in mice. Zaini J; Andarini S; Tahara M; Saijo Y; Ishii N; Kawakami K; Taniguchi M; Sugamura K; Nukiwa T; Kikuchi T J Clin Invest; 2007 Nov; 117(11):3330-8. PubMed ID: 17975668 [TBL] [Abstract][Full Text] [Related]
13. Combinational immunotherapy for established tumors with engineered tumor vaccines and adenovirus-mediated gene transfer. Xiang J; Chen Y; Moyana T Cancer Gene Ther; 2000 Jul; 7(7):1023-33. PubMed ID: 10917205 [TBL] [Abstract][Full Text] [Related]
14. Introduction of OX40 ligand into lymphoma cells elicits anti-lymphoma immunity in vivo. Kaneko H; Hori T; Yanagita S; Kadowaki N; Uchiyama T Exp Hematol; 2005 Mar; 33(3):336-43. PubMed ID: 15730857 [TBL] [Abstract][Full Text] [Related]
15. Multiple levels of activation of murine CD8(+) intraepithelial lymphocytes defined by OX40 (CD134) expression: effects on cell-mediated cytotoxicity, IFN-gamma, and IL-10 regulation. Wang HC; Klein JR J Immunol; 2001 Dec; 167(12):6717-23. PubMed ID: 11739485 [TBL] [Abstract][Full Text] [Related]
16. Critical contribution of OX40 ligand to T helper cell type 2 differentiation in experimental leishmaniasis. Akiba H; Miyahira Y; Atsuta M; Takeda K; Nohara C; Futagawa T; Matsuda H; Aoki T; Yagita H; Okumura K J Exp Med; 2000 Jan; 191(2):375-80. PubMed ID: 10637281 [TBL] [Abstract][Full Text] [Related]
17. Tumor suppression induced by intratumor administration of adenovirus vector expressing NK4, a 4-kringle antagonist of hepatocyte growth factor, and naive dendritic cells. Kikuchi T; Maemondo M; Narumi K; Matsumoto K; Nakamura T; Nukiwa T Blood; 2002 Dec; 100(12):3950-9. PubMed ID: 12393687 [TBL] [Abstract][Full Text] [Related]
18. Dendritic cells transduced with gp100 gene by RGD fiber-mutant adenovirus vectors are highly efficacious in generating anti-B16BL6 melanoma immunity in mice. Okada N; Masunaga Y; Okada Y; Mizuguchi H; Iiyama S; Mori N; Sasaki A; Nakagawa S; Mayumi T; Hayakawa T; Fujita T; Yamamoto A Gene Ther; 2003 Oct; 10(22):1891-902. PubMed ID: 14502218 [TBL] [Abstract][Full Text] [Related]
19. Adenovirus vector-mediated overexpression of a truncated form of the p65 nuclear factor kappa B cDNA in dendritic cells enhances their function resulting in immune-mediated suppression of preexisting murine tumors. Lee JM; Mahtabifard A; Yamada R; Crystal RG; Korst RJ Clin Cancer Res; 2002 Nov; 8(11):3561-9. PubMed ID: 12429647 [TBL] [Abstract][Full Text] [Related]